Antibiotic | Resistance n (%) | ESBL- Producing n = 54 | Non-ESBL producing n = 84 | P-value* |
---|---|---|---|---|
Cefotaxime | 70(50.7%) | 50(92.6) | 20(23.8) | < 0.001 |
Ceftazidime | 68(49.3%) | 51(94.4) | 17(20.2) | < 0.001 |
Ampicillin | 133(96.4%) | 53(98.1) | 80(95.2) | 0.37 |
Amoxycillin/ clavulanic acid | 96(69.6%) | 39(72.2) | 57(67.9) | 0.6 |
Imipenem | 9 (6.5%) | 4(7.4) | 5(0.001) | 0.7 |
Amikacin | 15(10.9%) | 6(11.1) | 9(10.7) | 0.9 |
Gentamicin | 53(38.4%) | 26(48.1) | 27(32.1) | 0.06 |
Nalidixic acid | 57(41.3%) | 28(61.6) | 29(34.5) | 0.04 |
Ciprofloxacin | 42(30.4%) | 25(46.3) | 17(20.2) | 0.001 |
Nitrofurantoin | 31(22.5%) | 11(20.4) | 20(23.8) | 0.6 |
Cotrimoxazole | 111(80.4%) | 49(90.7) | 62(73.8) | 0.014 |
Multi drug resistance | 93 (67.4%) | 47(87.0) | 46(54.8%) | < 0.001 |